Course of cognitive decline in Parkinson's disease: a meta-analysis
- PMID: 17942010
- DOI: 10.1017/S1355617707071160
Course of cognitive decline in Parkinson's disease: a meta-analysis
Abstract
A meta-analysis was conducted on 25 longitudinal studies involving 901 initially non-demented Parkinson's disease (PD) patients to examine the magnitude of decline across multiple cognitive domains associated with disease progression. Pooled effect sizes reflecting the standardized difference between baseline and follow-up neuropsychological performance were calculated for 8 cognitive domains using a random-effects model. Relatively small effect sizes were found across all cognitive domains (d = .00 - .40). During a mean follow-up interval of 29 months, significant declines were detected in global cognitive ability (d = .40), visuoconstructive skills (d = .32), and memory (d = .29). Age showed a significant relation with decline in global cognitive ability and memory. Lower educational level was associated with greater decline in all cognitive domains. Studies with longer follow-up intervals yielded larger effect sizes for global cognitive ability. In non-demented PD patients, changes in cognitive functions over time appear to be modest. Educational level, age, and length of the follow-up interval are likely to affect the magnitude of decline in several domains. Methodological flaws, such as selection bias and uncontrolled practice effects, may have caused underestimation of the true extent of decline.
Similar articles
-
Cognitive decline in Parkinson's disease: a prospective longitudinal study.J Int Neuropsychol Soc. 2009 May;15(3):426-37. doi: 10.1017/S1355617709090614. J Int Neuropsychol Soc. 2009. PMID: 19402929
-
Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.Neuropsychology. 2005 Jul;19(4):520-31. doi: 10.1037/0894-4105.19.4.520. Neuropsychology. 2005. PMID: 16060827
-
Cognitive decline in early Parkinson's disease.Mov Disord. 2009 Mar 15;24(4):605-8. doi: 10.1002/mds.22384. Mov Disord. 2009. PMID: 19191342
-
Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.Mov Disord. 2009 Jun 15;24(8):1103-10. doi: 10.1002/mds.22506. Mov Disord. 2009. PMID: 19353727 Review.
-
Progression of Cognitive Decline in Parkinson's Disease.J Parkinsons Dis. 2018;8(2):183-193. doi: 10.3233/JPD-181306. J Parkinsons Dis. 2018. PMID: 29914040 Free PMC article.
Cited by
-
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.Int J Mol Sci. 2023 Dec 29;25(1):498. doi: 10.3390/ijms25010498. Int J Mol Sci. 2023. PMID: 38203667 Free PMC article. Review.
-
Mild cognitive impairment in Parkinson's disease.Curr Neurol Neurosci Rep. 2011 Aug;11(4):371-8. doi: 10.1007/s11910-011-0203-1. Curr Neurol Neurosci Rep. 2011. PMID: 21487730 Review.
-
Neuropsychological profile in Chinese patients with Parkinson's disease and normal global cognition according to Mini-Mental State Examination Score.Int J Clin Exp Med. 2015 Aug 15;8(8):13755-61. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26550322 Free PMC article.
-
Mapping Actuarial Criteria for Parkinson's Disease-Mild Cognitive Impairment onto Data-Driven Cognitive Phenotypes.Brain Sci. 2021 Dec 30;12(1):54. doi: 10.3390/brainsci12010054. Brain Sci. 2021. PMID: 35053799 Free PMC article.
-
Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice.Cell Death Dis. 2018 Mar 2;9(3):352. doi: 10.1038/s41419-018-0381-8. Cell Death Dis. 2018. PMID: 29500411 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical